4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001179110-20-000546
Director acquired 60,186 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
JEFFS ROGER · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-01-10 | Exercise or conversion : show line 1 in the form | +9,127 | $9.00 | $82,143 | 65,747 | D |
| 2020-01-10 | Exercise or conversion : show line 2 in the form | +5,193 | $8.02 | $41,648 | 70,940 | D |
| 2020-01-10 | Exercise or conversion : show line 3 in the form | +11,000 | $4.95 | $54,450 | 81,940 | D |
| 2020-01-10 | Exercise or conversion : show line 4 in the form | +34,866 | $12.95 | $451,515 | 116,806 | D |
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-01-10 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −9,127 | 0 | D |
| 2020-01-10 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −5,193 | 0 | D |
| 2020-01-10 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −11,000 | 0 | D |
| 2020-01-10 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −34,866 | 0 | D |
Loading xslF345X03/edgar.xml…